Showing results (611-620 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|March 2, 2021
Genetic meta-analysis of cancer diagnosis following statin use identifies new associations and implicates human leukocyte antigen (HLA) in womenMaxine Sun, Audrey Lemaçon, Marc-André Legault, et al.
The Pharmacogenomics Journal|March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patientsSara Demurtas, Nicla La Verde, Selene Rota, et al.
The Pharmacogenomics Journal|March 18, 2021
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genesE O'Connell, I S Reynolds, M Salvucci, et al.
The Pharmacogenomics Journal|January 8, 2014
Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot studyD S L Toh, L L Tan, D C W Aw, et al.
The Pharmacogenomics Journal|January 22, 2014
A rare loss-of-function SCN5A variant is associated with lidocaine-induced ventricular fibrillationQ Xiong, L Cao, J Hu, et al.
The Pharmacogenomics Journal|January 15, 2014
Gene-based association identifies SPATA13-AS1 as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groupsB Padhukasahasram, J J Yang, A M Levin, et al.
The Pharmacogenomics Journal|June 25, 2014
Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trialV Le Morvan, S Litière, A Laroche-Clary, et al.
The Pharmacogenomics Journal|June 4, 2014
A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek populationY Vasilopoulos, C Sarri, E Zafiriou, et al.
The Pharmacogenomics Journal|August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimenE Cecchin, M D'Andrea, S Lonardi, et al.
The Pharmacogenomics Journal|October 4, 2012
A genetic basis for the variable effect of smoking/nicotine on Parkinson's diseaseE M Hill-Burns, N Singh, P Ganguly, et al.
Pageof 135